Open access · CC-BY
via OpenAlex
Emerging biological therapies for healthy aging: targeting inflammaging, senescence, and regenerative decline
Muhammad Shafique Khan, Mengyu Liu, Aymen Safdar, Mehreen Malik, Khalid Jamaan Alzahrani, Khalaf F. Alsharif, Fuad M. Alzahrani, Ataullah Khan, Shahid Hussain, Chien-Chin Chen
Stem Cell Research & Therapy · 2026
Cellular senescence
Stem-cell exhaustion
Chronic inflammation
Stem-cell therapy
Human
Preclinical / animal
Review
Abstract
Aging is a complex, multifactorial biological process marked by progressive physiological decline and increased vulnerability to chronic disease. Advances in geroscience have expanded the telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition) into twelve interrelated mechanisms categorized as primary, antagonistic, and integrative. Emerging biological therapies—including mesenchymal stem cell (MSC) therapies, stem cell-derived extracellular vesicles (EVs), monoclonal antibodies (mAbs), and plasma-based approaches—do not map onto these hallmarks in simple one-to-one relationships; rather, they exert pleiotropic effects across systemic inflammatory, metabolic, and regenerative networks. This review compiles current evidence on emerging biological treatments, highlighting early-phase immunomodulatory effects, cell-free alternatives for matrix remodeling, precision inflammatory control via mAbs, and systemic circulating signals. Despite promising preclinical and early clinical findings, translational challenges—including safety validation, production standardization, scalability, and long-term efficacy—must be addressed to establish mechanism-based anti-aging interventions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13287-026-05287-9
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Khan, M.S., Liu, M., Safdar, A., Malik, M., Alzahrani, K.J., Alsharif, K.F., Alzahrani, F.M., Khan, A., Hussain, S., & Chen, C. (2026). Emerging biological therapies for healthy aging: targeting inflammaging, senescence, and regenerative decline. <em>Stem Cell Research & Therapy</em>. https://doi.org/10.1186/s13287-026-05287-9
Vancouver
Khan MS, Liu M, Safdar A, Malik M, Alzahrani KJ, Alsharif KF, et al. Emerging biological therapies for healthy aging: targeting inflammaging, senescence, and regenerative decline. Stem Cell Research & Therapy. 2026. doi:10.1186/s13287-026-05287-9.
BibTeX
@article{muhammad2026Emergi,
title = {Emerging biological therapies for healthy aging: targeting inflammaging, senescence, and regenerative decline},
author = {Muhammad Shafique Khan and Mengyu Liu and Aymen Safdar and Mehreen Malik and Khalid Jamaan Alzahrani and Khalaf F. Alsharif and Fuad M. Alzahrani and Ataullah Khan and Shahid Hussain and Chien-Chin Chen},
journal = {Stem Cell Research & Therapy},
year = {2026},
doi = {10.1186/s13287-026-05287-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Aging 2026
Open access · CC-BY
Proteomics of aging: biomarkers for physiological systems and diseases
Frontiers in aging 2026
Open access · OA
Proteomics of aging: biomarkers for physiological systems and diseases.
World Journal of Cardiology 2026
Open access · CC-BY
Cardiovascular aging as a modifiable biological process: Mechanisms, clinical phenotypes, and translational opportunities
European Journal of Immunology 2026
Open access · CC-BY
Inflammaging: Experimental Insights and Translational Advances
European journal of immunology 2026
Open access · OA
Inflammaging: Experimental Insights and Translational Advances.
Stem Cells Translational Medicine 2022
Open access · CC-BY